YouYoung Levofloxacin Injection (Levofloxacin Hemihydrate)

Adult administration

Administer by IV infusion 1-2 times daily. The dosing regimen is determined based on the type and severity of the infection and susceptibility. After the initial few days of IV infusion, it may be switched to oral administration based on the patient's condition; the dosage remains the same. Administration should be done only via IV infusion, once or twice daily, for a maximum of 14 days. The infusion time is at least 60 minutes. Dosage for patients with normal renal function (creatinine clearance > 50ml/min): -

This drug may cause tendon-related side effects such as tendonitis and tendon rupture; therefore, if there is pain or inflammation in the tendons, use should be discontinued immediately. Additionally, there is a risk of exacerbation of symptoms in cases of peripheral neuropathy, central nervous system abnormalities, and in patients with myasthenia gravis, so caution is required. This drug should only be used when treatment for specific infections is necessary and should be administered restrictively to patients with no alternative treatment options. Administering must adhere to the injection speed; if blood pressure drops significantly or severe side effects occur, administration should be stopped immediately. The risk of tendon damage is increased in elderly patients, renal impairment patients, and when used concomitantly with corticosteroids, so combination should be avoided. Hypersensitivity or severe allergic reactions may occur; if symptoms such as skin rash or difficulty breathing appear, the drug should be stopped immediately, and medical consultation is advised. Gastrointestinal symptoms may include nausea, diarrhea, loss of appetite, vomiting, abdominal pain, indigestion, abdominal bloating, constipation, headache, dizziness, drowsiness, insomnia, neurosis, sensory disturbances, tremors, anxiety, agitation, confusion, tachycardia, hypotension, joint pain, muscle pain, redness and pain at the injection site, injection site infections, phlebitis, weakness, fungal overgrowth, vaginitis, candidiasis, fungal infections, ascites, skin hyperpigmentation, hypoglycemia, elevated serum creatinine. Serious side effects include hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, airway obstruction (bronchospasm), shortness of breath, difficulty breathing or respiratory distress, asthma attack, cough accompanied by fever or respiratory abnormalities, jaundice (skin or eyes turning yellow), severe malaise, hepatic abnormalities (jaundice).

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions. Severe rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions. Airway obstruction (bronchospasm), shortness of breath, difficulty breathing or respiratory distress, asthma attack, cough accompanied by fever or respiratory abnormalities. Jaundice (skin or eyes turning yellow), severe malaise, hepatic abnormalities (jaundice).

Mild side effects

• Itching
• rash
• nausea
• diarrhea
• loss of appetite
• vomiting
• abdominal pain
• indigestion
• abdominal bloating
• constipation

This drug should be stored in a sealed container that blocks light and at a temperature between 1°C and 30°C. Proper storage will maintain the drug's effectiveness and prevent deterioration.

Appearance

A colorless and transparent vial injectable solution containing a clear yellow liquid with a light green tint.

Package unit

For domestic use: 50mL, 100mL/vial x 10